Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer evolution to preinvasive management.

James L Mulshine1, Frank Cuttitta, Melvyn S Tockman

  • 1Intervention Section, Medicine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. mulshinj@mail.nih.gov

Clinics in Chest Medicine
|March 21, 2002
PubMed
Summary

Lung cancer screening lacks established evidence, unlike other major cancers. New cellular diagnostic platforms and biomarker research, such as hnRNP A2/B1, show promise for early lung cancer detection and improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung cancer screening with AI can discover cures for many early diseases. A public utility can make sure it happens.

Frontiers in oncology·2026
Same author

Cripto-1 and Cripto-3 differential expression pattern in human placenta, umbilical cord and fetal tissues suggests new functions for these proteins.

Scientific reports·2025
Same author

Current evidence of low-dose CT screening benefit.

European journal of cancer (Oxford, England : 1990)·2025
Same author

CT acquisition protocols for lung cancer screening-current landscape and the urgent need for consistency.

Insights into imaging·2025
Same author

AI integrations with lung cancer screening: Considerations in developing AI in a public health setting.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer.

European journal of cancer (Oxford, England : 1990)·2025

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Diagnostic Technologies

Background:

  • Established cancer screening protocols exist for cervical, breast, and colon cancers, with prostate cancer screening broadly used but lacking clear evidence.
  • Lung cancer screening faces significant logistical challenges, including cost-effectiveness and precise classification of at-risk populations.
  • The development of a cellular diagnostic screening platform for lung cancer is informed by advancements in cervical cancer screening, particularly automated image analysis.

Purpose of the Study:

  • To explore the potential of new approaches for lung cancer screening, drawing parallels with established cancer screening practices.
  • To investigate the role of biomarkers, such as hnRNP A2/B1, in the early detection of lung cancer.
  • To outline the necessary infrastructure for a prevention-oriented lung cancer care system.

Related Experiment Videos

Main Methods:

  • Review of existing cancer screening methodologies and their associated challenges.
  • Analysis of research linking hnRNP A2/B1 overexpression to lung cancer development.
  • Consideration of technological advancements in diagnostic precision, such as automated image analysis.

Main Results:

  • Overexpression of hnRNP A2/B1 has been significantly associated with the development of lung cancer in multiple independent studies.
  • Cellular diagnostic platforms require optimized cell preparation, reproducibility, and assay precision for successful lung cancer detection.
  • Lung cancer remains a leading cause of cancer death due to the lack of a validated screening tool, unlike other major cancers.

Conclusions:

  • New technologies offer opportunities for early lung cancer detection and management.
  • Further clinical trials are essential to validate the efficacy of novel screening approaches for lung cancer.
  • A comprehensive, prevention-oriented lung cancer care system requires sustained effort and a robust global infrastructure.